Investors
List of the current and past investors into Genocea Biosciences Inc with their respective financial instruments.| Investor | Profile | Country | Phone | Round | |||
|---|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Alexandria Real Estate Equities Inc | United States | +1 (626) 578-0777 | N/A | |||
|
|
Alexandria Real Estate Equities Inc | United States | 6265780777 | N/A | |||
|
|
Alexandria Real Estate Equities Inc | United States | (626) 578-0777 | N/A | |||
|
Auriga Partners | France | +33 (1) 5330-0707 | Series B | |||
|
|
Cycad Group LLC | United States | +1 (805) 684-6515 | Series B | |||
|
Johnson & Johnson Innovation LLC (JJDC Inc), (Johnson & Johnson Development Corp Inc) | Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. | United States | +1 (732) 524-3218 | Series B | ||
|
Lux Capital Management LLC | Research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences | United States | +1 (646) 475-4385 | Series B | ||
|
Polaris Venture Partners Inc | Multistage venture capital investors with focus Technology, Healthcare and Consumer | United States | +1 (781) 290-0770 | Series B | ||
|
Skyline Ventures | Life Sciences venture capital firm | United States | +1 (203) 564-1596 | Series B | ||
|
SR One Ltd | The venture capital unit of GlaxoSmithKline | United States | +1 (610) 567-1000 | Series B |